| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -5.65M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, CLRB returned -46.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -12.2% |
| 1 year | -46.9% |
| 5 years | -99.2% |
| 10 years | -100.0% |
| All-time high | $307,529,984.00 (Nov 2005) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in CLRB would be worth today ›No. Cellectar Biosciences, Inc. has not paid a dividend in the past 12 months.
Cellectar Biosciences, Inc. stock trades on NASDAQ under the ticker symbol CLRB.
Cellectar Biosciences, Inc. is part of the Healthcare sector.
Cellectar Biosciences, Inc. has a market cap of 24.48M USD, based on the latest quote.
Cellectar Biosciences, Inc. is scheduled to report earnings on Nov 12, 2026.
